A retrospective analysis of the prevalence of EGFR or KRAS mutations in patients (pts) with crizotinib-naive and crizotinib-resistant, ALK-positive non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Gainor, J. F.; Varghese, A. M.; Ou, S. H. I.; Kabraji, S.; Awad, M. M.; Katayama, R.; Pawlak, A.; Mino-Kenudson, M.; Yeap, B. Y.; Riely, G. J.; Iafrate, A. J.; Arcila, M. E.; Ladanyi, M.; Engelman, J. A.; Dias-Santagata, D.; Shaw, A. T.
Abstract Title: A retrospective analysis of the prevalence of EGFR or KRAS mutations in patients (pts) with crizotinib-naive and crizotinib-resistant, ALK-positive non-small cell lung cancer (NSCLC)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602562
PROVIDER: wos
Notes: Meeting Abstract: 8083 -- Source: Wos
MSK Authors
  1. Marc Ladanyi
    861 Ladanyi
  2. Gregory J Riely
    344 Riely
  3. Maria Eugenia Arcila
    336 Arcila
Related MSK Work